Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Immix Biopharma, Inc.
Report date July 14, 2022 · Filed July 22, 2022 · Amendment
Section 16 reporting ended · disclosed 2022-07-22. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 899,800 |
Reported balance
After 2022-07-14 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2022-07-14 · Sale · Disposed 200 · Balance 899,800 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 14, 2022 Filed Jul 18, 2022 21:09 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | SaleCommon Stock | 200 | $2.75 | $550.00 |
DisclosureSEC source: 0001493152-22-019731 · ownership.xml · nonDerivative · entry 1 Senn Sean · CIK 0001904837 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 899,800 Read SEC document |
| July 14, 2022 Filed Jul 22, 2022 20:12 UTC Amendment | Immix Biopharma, Inc. IMMX · Entity 4958 | SaleCommon Stock | 200 | $2.75 | $550.00 |
DisclosureSEC source: 0001493152-22-020155 · ownership.xml · nonDerivative · entry 1 Senn Sean · CIK 0001904837 · Under 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 899,800 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.